Diltiazem
( DrugBank: Diltiazem / KEGG DRUG: Diltiazem hydrochloride, Diltiazem malate, Diltiazem )
3 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
51 | Scleroderma | 1 |
58 | Hypertrophic cardiomyopathy | 1 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
88 | Chronic thromboembolic pulmonary hypertension | 1 |
51. Scleroderma
Clinical trials : 639 / Drugs : 551 - (DrugBank : 157) / Drug target genes : 135 - Drug target pathways : 222
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
58. Hypertrophic cardiomyopathy
Clinical trials : 181 / Drugs : 136 - (DrugBank : 40) / Drug target genes : 49 - Drug target pathways : 187
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
88. Chronic thromboembolic pulmonary hypertension
Clinical trials : 174 / Drugs : 99 - (DrugBank : 19) / Drug target genes : 17 - Drug target pathways : 79
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|